Browsing Tag
cobas eplex RP3
1 post
Roche wins FDA clearance for 19-pathogen respiratory test as laboratories face rising diagnostic demand
Roche has received US regulatory clearance for its cobas eplex respiratory pathogen panel 3, introducing more flexible testing configurations and expanded detection capabilities. The product strengthens its molecular diagnostics portfolio, but commercial adoption will depend on laboratory workflows, reimbursement and the economics of broad versus targeted respiratory testing.